Sign in
Not yet taking people in United StatesNo phase

Mitral Valve Repair With the Chord-X System: A Long Term Evaluation

Key facts

Who runs it
Artivion Inc.
Where
Edgewood, United StatesSee the siteAlso in 2 other countries, 3 sites
Trial code
Status
Not yet recruiting
People taking part
110 people, planned
Started
Jun 2026
Expected to end
Jun 2034
Type of study
Observational
Treatments tested
  • Chord-X system implant
Record updated
20 February 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Patient provided written Informed Consent
  • Patient underwent mitral valve procedure (defined as mitral valve surgical intervention via endoscopic, mini thoracotomy, or full sternotomy approach, including mitral annuloplasty with a ring, resection of mitral valve leaflets, and replacement of mitral chordae tendineae) using the Chord-X System as clinically indicated (i.e. not off-label) by Principal Investigator at research site
  • Patient's Chord-X System implant occurred no earlier than January 1, 2022
  • Patient is able and willing to participate in follow-up visits for the duration of the study (i.e. through 10 years post-op)

Who cannot take part

  • Patient was implanted with the Chord-X System prior to January 1, 2022
  • Patient has had previous mitral valve surgery
  • Patient underwent concomitant surgical procedures (except for maze procedure, PFO or LAA closure) at time of mitral repair procedure
  • Patient whose mitral valve procedure was performed as part of an emergency surgery (defined as a time period from diagnosis to surgery of ≤ 48 hours)
  • Patient with active or a history of endocarditis
  • Patient with congenital heart disease
  • Patient with an ejection fraction ≤ 50% at baseline
  • Patient was implanted with the Chord-X System off-label
  • Patient underwent a multi valve repair procedure
  • Patient with persistent or permanent atrial fibrillation

Where in United States

Also in 2 other countries, 3 sites

  • St. Elizabeth HealthcareEdgewood, United StatesContact: Cynthia MulcahyNot yet recruiting

About the trial

What the trial wants to find out

The goal of this clinical trial is to strengthen the evidence available for the Chord-X System by collecting follow-up data from patients who underwent Chord-X implant and to evaluate the long-term safety and performance data (out to 10 years). Collecting patient health information over time can help to supplement and improve the care of patients in the future.

Read full original descriptionShow less

Participants will:

Agree to the collection of their past medical history, and the details of their mitral repair surgery with the Chord-X system, including results of the follow-up examinations after implantation Visit the clinic for the routinely scheduled follow-up examination appointments

The group in the trial

  • Patients who underwent mitral repair with Chord-X system beginning in January 2022

    all patients who underwent a mitral valve procedure (defined as a mitral valve surgical intervention via either endoscopic, mini thoracotomy, or full sternotomy approach, including mitral annuloplasty with a ring, resection of mitral valve leaflets, and replacement of mitral chordae tendineae) using the Chord-X System, as clinically indicated, beginning in January 2022, will be approached for participation in the study.

    Treatment: Chord-X system implant

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 February 2026